Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
Bisacodyl is indicated to relieve occasional constipation and irregularity.
Synergy Research Site, St-Romuald, Quebec, Canada
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,, Indianapolis, Indiana, United States
Ospedale S.Maria delle Croci, Ravenna, RA, Italy
Alessandro Mussetto, Ravenna, RA, Italy
Oslo Universitetssykehus, Oslo, Norway
Hospital de Sabadell, Sabadell, Barcelona, Spain
Hotel Dieu Hospital, Kingston, Ontario, Canada
Louisiana Research Center LLC, Shreveport, Louisiana, United States
Indiana University Hospital, Indianapolis, Indiana, United States
Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States
Florida Clinical Research Group, Clearwater, Florida, United States
Gastroenterology Research Consultants of Greater Cincinnati, Cincinnati, Ohio, United States
Investigational site, Hollywood, Florida, United States
Gastroenterology Services, Downers Grove, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.